Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I’ve seen some big names make .25-.25 targets. Some short squeezes like this have gone to $1.00
This has been a great run the last month. The sky is the limit because of no debt and many shorts that need to cover. The chart looks beautiful too.
Definitely can’t wait to see how high it goes
It was definitely a strong power hour. How high you think this could go ?
Great run so far! This stock is showing some great potential. Can’t wait to see it through.
Yeah chart looks great. Higher highs and higher lows.
Or multiple days! I’m a chart and number trader and both are insane on oxys!
Look at the volume these past two weeks. It's been steadily increasing. Wouldn't be surprised if it hits 10m in one day soon
I do think I agree with you. If retail holds strong this could see a squeeze like I have never seen before... well at least never been in when it squeezes. Seen them happen from the sidelines and they are painful to watch when you miss it
I bought some today and I plan on buying more tomorrow. This one is fun to watch too. Market makers have tried so many games on this one
It’s even possible to buy tomorrow and still make 100% returns. .25 is not unlikely. We will see in the next couple days
Can’t believe it may actually hit that .15 price target. Actually, blow it away if all our numbers are correct...
My opinion, this is just the beginning.
And it’s coming up on 30 days where they have to cover. Squeeze has only just begun
That is one heck of a lot of shorts. I have not been doing the count but I would say probably around 7 to 8 million shares short now. What do you think? This is crazy.
I don't even know if this is linked to our OXYS - from a friend.
IOT-OXYS, Inc. and Subsidiaries
Notes to Unaudited Consolidated Financial Statements
March 31, 2018
1. NATURE OF OPERATIONS
On July 28, 2017, IIOT-OXYS, Inc., a Nevada corporation (the “Company”) (previously known as Gotham Capital Holdings, Inc.), the Company executed and closed the Securities Exchange Agreement dated effective March 16, 2017, between the Company, OXYS Corporation, a Nevada corporation (“OXYS”), and the shareholders of OXYS and changed its name to “IIOT-OXYS, Inc.” As a result of the Closing, the Company issued 34,687,244 shares on a pro rata basis to the shareholders of OXYS, and OXYS became a wholly owned subsidiary of the Company. In addition, the Company cancelled 1,500,000 outstanding shares held by principal shareholders of the Company, which resulted in a total of 38,453,328 shares issued and outstanding upon completion of the Closing.
On December 14, 2017, the Company entered into a Securities Exchange Agreement dated December 14, 2017, between the Company, OXYS, and HereLab, Inc., a Delaware corporation (“HereLab”), and the shareholders of HereLab. Upon completion of the closing of the Exchange Agreement, on January 11, 2018, the Company issued an aggregate of 1,650,000 shares of its common stock on a pro rata basis to the two shareholders of HereLab and HereLab became a wholly-owned subsidiary of the Company.
OXYS Corporation was incorporated on August 4, 2016 in Nevada. It maintains its principal office in Massachusetts at 705 Cambridge St., Cambridge, MA 02142.
The Company was only recently formed and is currently devoting substantially all its efforts in identifying, developing and marketing engineered products, software and services for applications in the Industrial Internet which involves collecting and processing data collected from a wide variety of industrial systems and machines.
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The Company's financial statements are prepared on the accrual method of accounting. The accounting and reporting policies of the Company conform with generally accepted accounting principles (GAAP).
Interim Financial Statements
The accompanying unaudited condensed interim financial statements and related notes have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information, and in accordance with the rules and regulations of the United States Securities and Exchange Commission with respect to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. The unaudited interim financial statements furnished reflect all adjustments (consisting of normal recurring adjustments) which are, in the opinion of management, necessary for a fair statement of the results for the interim periods presented. Interim results are not necessarily indicative of the results for the full year. These unaudited interim financial statements should be read in conjunction with the audited financial statements of the Company for the year ended December 31, 2017.
Principles of Consolidation
The consolidated financial statements for March 31, 2018 include the accounts of IIOT-OXYS, Inc., OXYS Corporation, and HereLab, Inc. All significant intercompany balances and transactions have been eliminated.
The consolidated financial statements for fiscal year 2017 include the accounts of IIOT-OXYS, Inc., and OXYS Corporation. All significant intercompany balances and transactions have been eliminated.
Any thoughts??
There were 1,644,509 shares shorted today according to Finra
http://regsho.finra.org/FORFshvol20180521.txt
The only way to communicate with the company is via twitter,
Come on POWER HOUR!!!
Jacob,
I’ve been a shareholder for quite some time. I’ve contacted the company on two different occasions in the last 30 days and get no response of any kind. How do you get any information about the financials of this company post 2016? How do you find out any information about how they’re doing currently?
Looks like a market sell check the time stamp
That would be a big dump! Somebody mighta dropped dead of a heart attack over that one!
Interesting 30,000 sold at .0001. I'm guessing 1 of 3 things. Fat finger (ouch), intentional dump to cause panic selling in order to grab cheaper shares, or possibly to reset the RSI? Although, perhaps none of the above, any other thoughts?
Tomorrow will tell a lot about the continuation
Looks like we have a nice bullish pennant forming. Tomorrow bodes well....
Well that’s a new one for me. Thanks for the insight.
Seperately we are approaching 3/8 of the float in volume today. Volume buzz will be way up tonight. expect new eyes in the morning.
If it’s under 10,000 shares it won’t show at this price point
Agreed. I just put in an order for some more at 0.087. Been about five minutes and it still isn’t in the L2. MMs are trying sooooo hard to to sell shares.
Some profit taking going on. Once it settles down will go back towards .15
Hold on tight. We knew this was coming (it’s why they were upping the bid yesterday and trailing it tight). Don’t give up those shares. That is exactly what they want!
Funny I haven’t seen fullcontactyoga around hahaha
It's exciting to watch this one. It was crazy watching all the bid jumping today. I think we see the squeeze happen very soon.
I have never seen MMs so desperate to cover. This thing could fly any day
Yes plenty of Gas left in the Tank.
If trading would have lasted one more hour we would have have had a major breakout. Shorts are getting so nervous. It is a thing of beauty.
Nothing to worry about here. It will have a parabolic breakout. It will happen by Monday and possibly tomorrow. The float is locked up. The 30 day mark is Monday naked shorts have been covering into each other but they end that after 30 days. This thing could hit .25 in minutes. Call up your broker and tell them you don't want your shares to be borrowed. Then ask how many shares are on the market available to short. They won't find any. This will be one of the biggest short squeezes in 2018.
My only concern were the MMs on the bid today. CANT absorbed a lot of shorts on the ask. It looked to me like the MMs wanted the pps to rise. Wasn’t expecting that. Need to think this through....
Great close today!
Silly MMs. Can’t you come up with a new game plan? Looking forward to this afternoon....
Agree and was glued to level 2 all day long. I think it's closer to 300k plus today but I could be wrong. I don't think it was much short covering because I know people who bought. That's why I think there is still a lot of covers yet to happen. Either way let's see this move up.
Followers
|
34
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1154
|
Created
|
01/16/13
|
Type
|
Free
|
Moderators |
OxySure Systems, Inc. (OXYS) is a medical technology company that focuses on the design, manufacture, and distribution of specialty respiratory and medical solutions. The company pioneered a safe and easy--to-use solution to produce medically pure (USP) oxygen from inert powders. The company owns numerous issued patents and patents pending on this technology which is designed to make the provision of emergency oxygen safer, more accessible, and easier to use than traditional oxygen provision systems.
OXYS' products improve access to emergency oxygen that affects the survival, recovery, and safety of individuals in several areas of need: (1) Public and private places and settings where medical emergencies can occur; (2) Individuals at risk for cardiac, respiratory, or general medical distress needing immediate help prior to emergency medical care arrival; and (3) Those requiring immediate protection and escape from exposure situations or oxygen-deficient situations in industrial, mining, military, or other "Immediately Dangerous to Life or Health" (IDLH) environments.
OXYS manufactures its products at a manufacturing facility in Frisco, Texas. The product has also been deployed in several other countries, including Brazil, Israel, Turkey and South Africa.
Investment Highlights
Media Coverage
Products
OXYS has developed a unique platform technology whereby medically pure oxygen is created instantly from two dry inert powders, allowing oxygen to be delivered on demand. Using this technology, the company has developed the OxySure Model 615.
With Model 615, there are no compressed tanks, no dials, no valves, no regulatory maintenance, no hydrostatic testing, no batteries, and no required training. The technology is both safe and easy-to-use for the layperson and is available over the counter. Like an AED or fire extinguisher, Model 615 can be placed just about anywhere a medical emergency might occur to help improve medical outcomes and save lives by bridging the gap between a medical emergency and the arrival of first responders on the scene.
(1. Plug in the Mask 2. Turn the Knob 3. Place the mask over the nose and mouth)
There is no storage of oxygen; the oxygen is created on demand. As a result, the Model 615 eliminates the dangers traditionally associated with compressed tanks.
Other unique characteristics:
Product Selling Points
OXYS’ Model 615 is a pioneering technology that is defining a new market with no direct competition, providing a solution to problems with existing emergency oxygen, such as:
Compressed Cylinders
Chemical Generators
Enormous Markets
OXYS is targeting enormous end markets that are at least as large as the install base for AEDs, which exceeds 2 million units, and potentially as large as the fire extinguisher base, which exceeds 100 million units in the U.S. (500+ million units globally).
Already Approved
Model 615 has already been cleared by the U.S. Food & Drug Administration for over-the-counter (OTC) sale without the need for a prescription, and is already in the commercialization phase.
Recurring Revenue Model
Model 615 consists of a reusable housing and a replaceable cartridge, which must be replaced after each use or upon expiry of a 2-year shelf life. Over time, this results in recurring revenues and greater earnings predictability.
Future products
OXYS’ “oxygen from powder” technology also allows the company to develop much needed solutions for other vertical markets such as aviation, mining, and sports & recreation markets.
Market Opportunity
OXYS has been primarily focused on establishing partnerships with distributors, as well as reaching out to large OEM customers that may be able to expand its presence in the marketplace.
The company’s aim is to bridge the gap between an emergency situation and the arrival of first responders. According to USA Today, this gap is currently an average 6-15 minutes. AEDs address this gap, but oxygen has always been missing. OXYS’ technology is applicable to an alarmingly high population of at-risk individuals:
OXYS’ Model 615 is currently installed internationally in a variety of locations, including:
The company believes that its technology has potential for market placement in:
School Mandates
OXYS believes that there is dire need for mandating emergency oxygen in schools, requiring that an FDA-cleared, non-compressed oxygen source suitable for use by lay rescuers be made widely available.
AEDs are currently mandated in schools in 24 states:
Oxygen administration is often the first requirement in a medical emergency. The standard of care (SOC) today for first responders is to administer oxygen immediately upon arrival. Having an AED nearby would enable nurses, teachers, school administrators, and athletic trainers to “bridge the gap” by applying oxygen sooner, improving medical outcomes and saving lives, as well as minimizing absenteeism and saving millions of dollars for school districts.
Growth Strategy & Sales Model
OXYS’ technologies target a number of enormous end markets. With plans to initially target the 102,265 educational campuses in the U.S., the 350,735 manufacturing facilities, the 350,000 churches, and the 950,000 restaurants, the company could see a relatively large installed base over the near-term.
In the long run, the company aims to place its technology in any public or private place where people are at risk. From recreational vehicles to restaurants to federal buildings, the potential end markets for the Model 615 are at least as numerous as AEDs (2+ million units) and potentially as large as fire extinguishers (100+ million) in the U.S. The markets outside of the U.S. increase the global market size for OXYS to at least 500+ million units.
The company aims to capitalize on these markets primarily through partnerships with distributors and OEM customers. To execute this goal, the company has created a blueprint for growth:
Increase Sales to Existing and New Customers
Introduce New Products / Services and Channels
Pursue Market Catalysts
Marketing support:
Outlook
In the next 3-5 years OXYS aims to add more than 100 new distributors and grow its direct sales force and strategic accounts teams to more than 500 individuals. OXYS also intends to pursue legislation and mandates that would require life-saving devices such as Model 615 in public facilities. In addition, OXYS will:
Management Team
Julian T. Ross, MBA, Chairman & CEO
Julian T. Ross is the OxySure founder, technology developer (holds 9 patents), and CEO. He has more than 25 years of experience in technology, manufacturing, and finance. He has managed development of production capabilities, partnerships and alliances, managed the development of sales, distribution and licensing partnerships, raised in excess of $14 million in debt and equity to fund operations, and took OXYS public in 2011 through an S-1 registration with the Securities and Exchange Commission. Ross’ other experience includes: roll-up, technology companies; $315 million high yield debt offering (Merrill Lynch/Salomon Brothers in lead, plus Deutsche Morgan Grenfell, Nomura Securities).
Jeremy “Jerry” Jones, Director
Jeremy Jones has more than 35 years in healthcare leadership. He was former chairman/CEO of Apria Healthcare (sold to Blackstone for $1.7 billion) and chairman of On Assignment (ASGN), a $1.3 billion healthcare services leader. His current and former boards include: CombiMatrix Corp. (CBMX); Byram Healthcare Centers Inc. (chairman); (3) Lifecare Solutions, Inc. (chairman) (4) US Labs, Inc. (acquired by Lab Corp in 2005; (5) Cardium Healthcare (acquired by CenCorp Health in 2006). He was formerly chairman of the Health Industry Distributors Association (HIDA) and is founding chairman of the Home Oxygen Services Coalition. He has also received the Dr. Jonas Salk Memorial Mentor in Medicine Award from the March of Dimes.
Vicki Jones, MBA, Director
Don Reed, BA, BS – Director
Dr. Vincent Mosesso, Jr., MD, FACEP – Advisory Board
Dr. James R. Winn, MD – Advisory Board
Dr. Thomas D. Franklin, Jr. – Advisory Board
Dr. Jonathan E. Burke, DMD – Advisory Board
Dr. R. Dean White, D.D.S., M.S. – Advisory Board
OxySure Systems, Inc. |
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |